Source:http://linkedlifedata.com/resource/pubmed/id/17005581
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-31
|
pubmed:abstractText |
The aim of the present study was to measure airway, oropharyngeal and gastrointestinal deposition of (99m)Tc-labelled hydrofluoroalkane-beclomethasone dipropionate after inhalation via a pressurised metered-dose inhaler and spacer (Aerochamber Plus) in asthmatic children. A group of 24 children (aged 5-17 yrs) with mild asthma inhaled the labelled drug. A total of 12 children took five tidal breaths after each actuation (tidal group). The other 12 children used a slow maximal inhalation followed by a 5 - 10-s breath-hold (breath-hold group). Simultaneous anterior and posterior planar gamma-scintigraphic scans (120-s acquisition) were recorded. For the tidal group, mean+/-sd lung deposition (% ex-actuator, attenuation corrected) was 35.4+/-18.3, 47.5+/-13.0 and 54.9+/-11.2 in patients aged 5-7 (n = 4), 8-10 (n = 4) and 11-17 yrs (n = 4), respectively. Oropharyngeal and gastrointestinal deposition was 24.0+/-10.5, 10.3+/-4.4 and 10.1+/-6.2. With the breath-hold technique, lung deposition was 58.1+/-6.7, 56.6+/-5.2 and 58.4+/-9.2. Oropharyngeal and gastrointestinal deposition was 12.9+/-3.2, 20.1+/-9.5 and 20.8+/-8.8. Inhalation of the extrafine formulation with the breath-hold technique showed significantly improved lung deposition compared with tidal breathing across all ages. Oropharyngeal and gastrointestinal deposition was markedly decreased, regardless of which inhalation technique was applied, compared with a previous paediatric study using the same formulation delivered via a breath-actuated metered-dose inhaler.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
299-306
|
pubmed:meshHeading |
pubmed-meshheading:17005581-Administration, Inhalation,
pubmed-meshheading:17005581-Adolescent,
pubmed-meshheading:17005581-Aerosols,
pubmed-meshheading:17005581-Anti-Asthmatic Agents,
pubmed-meshheading:17005581-Asthma,
pubmed-meshheading:17005581-Beclomethasone,
pubmed-meshheading:17005581-Child,
pubmed-meshheading:17005581-Child, Preschool,
pubmed-meshheading:17005581-Female,
pubmed-meshheading:17005581-Gastrointestinal Tract,
pubmed-meshheading:17005581-Humans,
pubmed-meshheading:17005581-Lung,
pubmed-meshheading:17005581-Male,
pubmed-meshheading:17005581-Metered Dose Inhalers,
pubmed-meshheading:17005581-Oropharynx,
pubmed-meshheading:17005581-Tissue Distribution
|
pubmed:year |
2007
|
pubmed:articleTitle |
Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children.
|
pubmed:affiliation |
UWA School of Paediatrics and Child Health, Princess Margaret Hospital for Children, GPO D184 Perth, Western Australia 6840, Australia. croller@meddent.uwa.edu.au
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|